RPAM
Rhenman & Partners Asset Management Portfolio holdings
AUM
$791M
This Quarter Return
+9.4%
1 Year Return
+12.81%
3 Year Return
+98.32%
5 Year Return
+175.58%
10 Year Return
+579.5%
AUM
$958M
AUM Growth
+$958M
(+0.36%)
Cap. Flow
+$840K
Cap. Flow
% of AUM
0.09%
Top 10 Holdings %
Top 10 Hldgs %
27.27%
Holding
97
New
7
Increased
32
Reduced
18
Closed
4
Top Buys
| 1 |
HCA Healthcare
HCA
|
$11.3M |
| 2 |
Medtronic
MDT
|
$8.55M |
| 3 |
Bio-Techne
TECH
|
$7.46M |
| 4 |
Tenet Healthcare
THC
|
$6.18M |
| 5 |
Cencora
COR
|
$6.13M |
Top Sells
| 1 |
ABMD
Abiomed Inc
ABMD
|
$21.7M |
| 2 |
Intuitive Surgical
ISRG
|
$11.9M |
| 3 |
UnitedHealth
UNH
|
$8.91M |
| 4 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
$8.1M |
| 5 |
Thermo Fisher Scientific
TMO
|
$6.88M |
Sector Composition
| 1 | Healthcare | 99.1% |
| 2 | Industrials | 0.43% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Inspire Medical Systems
INSP
$2.53B
| $15.4M | 1.6% |
61,000
-2,000
| -3% | -$504K |
|
27
McKesson
MCK
$85.9B
| $14.6M | 1.53% |
39,000
-11,000
| -22% | -$4.13M |
|
|
AXNX
28
DELISTED
Axonics, Inc. Common Stock
AXNX
| $14.4M | 1.5% |
230,000
+20,000
| +10% | +$1.25M |
|
|
MRTX
29
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $13.6M | 1.42% |
300,000
+102,933
| +52% | +$4.66M |
|
30
Danaher
DHR
$143B
| $13.3M | 1.38% |
50,000
-12,000
| -19% | -$3.19M |
|
31
Harmony Biosciences
HRMY
$2.16B
| $13.2M | 1.38% |
240,000
+3,000
| +1% | +$165K |
|
32
Abbott
ABT
$230B
| $12.8M | 1.34% |
117,000
| – | – |
|
33
Edwards Lifesciences
EW
$47.7B
| $10.7M | 1.12% |
144,000
+19,000
| +15% | +$1.42M |
|
|
SILK
34
DELISTED
Silk Road Medical, Inc. Common Stock
SILK
| $10.4M | 1.08% |
195,871
+40,871
| +26% | +$2.16M |
|
35
Apellis Pharmaceuticals
APLS
$3.51B
| $10.3M | 1.08% |
200,000
-20,000
| -9% | -$1.03M |
|
36
Neurocrine Biosciences
NBIX
$13.5B
| $10.2M | 1.06% |
85,000
+2,000
| +2% | +$239K |
|
37
Cytokinetics
CYTK
$5.98B
| $9.91M | 1.03% |
216,322
+6,322
| +3% | +$290K |
|
|
SWAV
38
DELISTED
Shockwave Medical, Inc. Common Stock
SWAV
| $9.66M | 1.01% |
47,000
+27,000
| +135% | +$5.55M |
|
39
Outset Medical
OM
$245M
| $9.3M | 0.97% |
360,000
+20,000
| +6% | +$516K |
|
|
ISEE
40
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
| $9.21M | 0.96% |
430,000
+65,000
| +18% | +$1.39M |
|
41
Immunocore
IMCR
$1.78B
| $8.56M | 0.89% |
150,000
| – | – |
|
42
Insulet
PODD
$24.2B
| $8.54M | 0.89% |
29,000
| – | – |
|
43
Royalty Pharma
RPRX
$15.8B
| $8.5M | 0.89% |
215,000
| – | – |
|
44
Privia Health
PRVA
$2.84B
| $8.4M | 0.88% |
370,000
+93,000
| +34% | +$2.11M |
|
45
Dynavax Technologies
DVAX
$1.19B
| $8.34M | 0.87% |
783,519
+50,000
| +7% | +$532K |
|
46
Biogen
BIIB
$20.8B
| $8.31M | 0.87% |
30,000
-2,782
| -8% | -$770K |
|
|
RVNC
47
DELISTED
Revance Therapeutics, Inc.
RVNC
| $8.09M | 0.84% |
438,000
+50,000
| +13% | +$923K |
|
48
Xencor
XNCR
$594M
| $7.66M | 0.8% |
294,076
| – | – |
|
|
49
Bio-Techne
TECH
$8.3B
| $7.46M | 0.78% |
+90,000
| New | +$7.46M |
|
|
IMGN
50
DELISTED
Immunogen Inc
IMGN
| $7.44M | 0.78% |
1,500,000
+400,000
| +36% | +$1.98M |
|